Adaptive Biotechnologies People in the News: New Appointments at BD, Adaptive Biotechnologies, ChromaCode, More Adaptive Biotechnologies Q2 Revenues Jump 83 Percent Test volume for ClonoSeq, its assay for minimal residual disease monitoring in blood cancers, grew 75 percent year over year and 15 percent sequentially. Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics Premium The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end. GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month. FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test The test leverages immune repertoire sequencing technology to identify individuals who have had a recent or prior SARS-CoV-2 infection. Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Feb 23, 2021 Adaptive Biotechnologies, LabCorp Expand Collaboration Jan 29, 2021 People in the News: New Appointments at Adaptive Biotechnologies, BD, Seven Bridges, More Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 11, 2021 Adaptive Biotechnologies, AstraZeneca Collaborate on Mapping Immune Response in Cancer Dec 21, 2020 Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay Dec 8, 2020 NGS Bests Flow Cytometry for MRD-Based Prediction of ALL Relapse, Survival, ASH Study Suggests Premium Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Premium Nov 11, 2020 Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing Nov 10, 2020 Adaptive Biotechnologies Q3 Revenues Grow 1 Percent Sep 9, 2020 Adaptive Biotechnologies, Takara Bio T Cell Receptor Sequencing Methods Rank High in Benchmarking Study Premium Aug 10, 2020 Adaptive Biotechnologies Q2 Revenues Fall 5 Percent, Beat Analyst Estimates Aug 7, 2020 New Products Posted to GenomeWeb: Illumina, Adaptive Biotechnologies, Personalis, More Aug 6, 2020 Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay Aug 4, 2020 GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development Jul 16, 2020 Adaptive Biotechnologies to Raise $240M in Public Stock Offering Jun 12, 2020 New Products Posted to GenomeWeb: Stilla Technologies, Adaptive Biotechnologies, Lexogen, More May 13, 2020 Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19 Premium May 12, 2020 Adaptive Biotechnologies Q1 Revenues Grow 65 Percent Load More Breaking News People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.